FT.com / Search

1-10 of 68,615 results for Elan Microelectronics Corporation v. Apple, Inc.

Sorry, we found no matches with all of your words. Here are the nearest matches with some of the words.

FT Suggests - Try these pages on FT.com

Sort by:

Relevance
Date

9:20am
Wolfson hurt by poor consumer demand
Wolfson Microelectronics, the audio chip designer, wrote off a poor 2009 but said the ground had been prepared for an upturn this year by seeing...been expected. Wolfson had hoped its high-profile failure to put its chips into the top-selling latest version of Apple’s iPhone, the 3GS, would be covered by increased sales of other consumer gadgets like flat screen televisions... By Philip Stafford
May 6, 2009
Elan
...it is hard to see how it would address Elan’s deeper strategic challenges. Even...problems. BACKGROUND NEWS Shares in Elan Corporation surged by as much as 20 per cent on...preparing a bid for the group. Lundbeck and Elan declined to comment. Elan announced...
May 5, 2009
Elan shares soar on bid rumours
Shares in Elan Corporation surged by as much as 20 per cent on Tuesday amidst rumours...Lundbeck was preparing a bid for the group. Lundbeck and Elan declined to comment. Elan announced in January that it had appointed Citigroup to conduct... By John O’Doherty
September 15, 2009
Elan revises J&J deal to appease Biogen
Elan, the Irish domiciled biotech company, will receive $115m less than...changing aspects of J&J’s $1.5bn recapitalisation deal with Elan announced in July. Elan said the new terms allowed it to respect the deadline endorsed by... By Andrew Jack in London
September 4, 2009
Elan dealt a blow with Biogen ruling
Elan, the Irish domiciled pharmaceuticals company...Manhattan federal court judge, ruled that Elan had breached the terms of its contract with...damage. The decision marked a failure in Elan’s strategy to swiftly seek a suspension of... By Andrew Jack in London
August 6, 2009
Elan starts legal action in drug row with Biogen
Elan has launched legal action to prevent the...from Biogen Idec, based in Boston, that Elan’s recent $1.5bn (£893m) deal with Johnson...In a filing with the US District Court, Elan said it had received a letter from Biogen... By Andrew Jack
October 21, 2009
Elan pins hopes on multiple sclerosis drug
Kelly Martin, chief executive of Elan, said the Irish drugs group would focus...in Europe and the US taking the drug. Elan has a 10 per cent share of the market for...share from the market leader Copaxone. Elan’s long-term aim is for Tysabri to occupy... By John O’Doherty
January 21, 2010
SEC litigation release for General Re
...Securities and Exchange Commission v. General Re Corporation, Civil Action No. 10 Civ...SEC Charges General Re Corporation for Role in AIG and Prudential...Commission today charged General Re Corporation for its involvement in separate...and Prudential Financial, Inc. to manipulate and falsify... By
October 23, 2009
Elan hit by Tysabri questions
Irish drugs group Elan plunged 20.5 per cent to €3.42 on...a multiple sclerosis drug produced by Elan and Biogen Idec, a US biotechnology group...to appear more frequently. Tysabri was Elan’s “key revenue and cash generator... By Courtney Weaver
2:00am
Disney chief hails Apple's iPad
...of Walt Disney, delivered a ringing endorsement of Apple's iPad yesterday and said the media company was...said.Disney, which has a close relationship with Apple - Steve Jobs, Apple's chief executive, is one of Disney's biggest... By Matthew Garrahan